Pediatric Formula Best Effort Presumption Is Built Into Exclusivity - Botstein
Executive Summary
The expectation that drug manufacturers will use their best efforts to develop pediatric formulations is "built in" to FDA's pediatric exclusivity presumptions, former FDA Office of Drug Evaluation III Director Paula Botstein, MD, said June 3 at a Barnett Pediatric Drug Development meeting in Philadelphia, Pa.